MEX3A promotes development and progression of breast cancer through regulation of PIK3CA

The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I

(2020) Francesca Bufalieri et al.   Cancers

MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway

(2020) Shujun Jiang et al.   EXPERIMENTAL CELL RESEARCH

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Breast Cancer Treatment

(2019) Adrienne G. Waks et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer

(2019) Xin-Ge Zhao et al.   Cell Death & Disease

BRCA1/2 testing: therapeutic implications for breast cancer management

(2018) Nadine M. Tung et al.   BRITISH JOURNAL OF CANCER

PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation

(2018) Yunhai Li et al.   CANCER LETTERS

Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway

(2018) Ramón García-Escudero et al.   ORAL ONCOLOGY

PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer

(2018) Anthony Adimonye et al.   PLoS One

PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis

(2018) Hongwei Fan et al.   Thoracic Cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor–Positive Advanced Breast Cancer

(2018) Dejan Juric et al.   JAMA Oncology

Revisiting the Role of Bevacizumab in the Treatment of Breast Cancer

(2017) Leticia Varella et al.   SEMINARS IN ONCOLOGY

Radiotherapy for breast cancer: The predictable consequences of an unmet need

(2016) Danielle Rodin et al.   BREAST

Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer

(2016) Yuan Tang et al.   Clinical Breast Cancer

Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies

(2016) Vivek Asati et al.   CURRENT PHARMACEUTICAL DESIGN

Clinical Diagnosis and Management of Breast Cancer

(2016) E. S. McDonald et al.   JOURNAL OF NUCLEAR MEDICINE

Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling

(2016) L Du et al.   ONCOGENE

Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors

(2016) A. C. V. Krepischi et al.   Molecular Cytogenetics

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

(2015) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness

(2013) Bruno Pereira et al.   NUCLEIC ACIDS RESEARCH

Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells

(2012) HONG JIANG et al.   Molecular Medicine Reports

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure

(2010) J L Dean et al.   ONCOGENE

Structure and function of KH domains

(2008) Roberto Valverde et al.   FEBS Journal